Zumutor Biologics

Zumutor Biologics

Zumutor Biologics is a biotech startup focused on developing immuno-oncology therapies that harness the body's innate immune system to fight cancer. The company is advancing its clinical trials for its lead drug candidate ZM008, which is designed to enhance the immune system’s ability to target and destroy cancer cells. This funding round will support ongoing and future clinical trials, including Phase 1 and Phase 2 studies.

Total raised
$7.3M
tracked to date
Latest round
Pre-Series B
Jun 15, 2026
Known investors
5
led by Accel
Press coverage
4
outlets tracked

Is this your company?

Claim this profile to get matched with investors who fund Health startups in India.

Claim this profile →

🏆 Featured in Datapile’s Q2 2026 India Funding Report

Read the Q2 2026 India report →
Add this badge to your site
<a href="https://datapile.co/reports/q2-2026-india-startup-funding" target="_blank" rel="noopener" style="display:inline-flex;align-items:center;gap:8px;padding:9px 16px;border-radius:9999px;background:#0B1224;color:#ffffff;font:600 13px/1.2 -apple-system,BlinkMacSystemFont,'Segoe UI',Roboto,Arial,sans-serif;text-decoration:none;border:1px solid #7C5CFF"><span style="display:inline-block;width:11px;height:11px;border-radius:3px;background:#7C5CFF"></span>Featured in Datapile&rsquo;s Q2 2026 India Funding Report</a>

Funding history

  1. 1
    $7.3MPre-Series BJun 15, 2026

    Led by Accel

    Announcement ↗

Founder

Kavitha Iyer Rodrigues
Kavitha Iyer Rodrigues

Investors in Zumutor Biologics

Backers from this company's tracked funding rounds.

Zumutor Biologics in the news

Coverage of this company's funding, tracked by Datapile.

More Health companies

Recently funded startups in the same category.

Related on Datapile